Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-002578
Filing Date
2025-04-10
Accepted
2025-04-10 15:21:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3030
  Complete submission text file 0001959173-25-002578.txt   4467
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Subject) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36182 | Film No.: 25828071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XENCOR 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address
Cornelissen Bart Jan (Reporting) CIK: 0002018934 (see all company filings)

Type: 144